Wellgistics Health, Inc.
WGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | -0.25 | -17.99 | 0.00 |
| FCF Yield | -0.81% | -0.20% | 0.00% |
| EV / EBITDA | -45.21 | -59.39 | -487.84 |
| Quality | |||
| ROIC | -19.30% | 130.91% | 65,194.84% |
| Gross Margin | 9.75% | 0.00% | 17.54% |
| Cash Conversion Ratio | 0.18 | 0.12 | – |
| Growth | |||
| Revenue 3-Year CAGR | -17.92% | -100.00% | 3,200,216.64% |
| Free Cash Flow Growth | -358.93% | 0.00% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | -4.90 | -0.24 | 0.00 |
| Interest Coverage | -7.39 | -191.01 | -11.92 |
| Efficiency | |||
| Inventory Turnover | 1.72 | 0.00 | 0.00 |
| Cash Conversion Cycle | 146.45 | 0.00 | -0.07 |